mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
mRNA technologies have recently proven clinical efficacy against coronavirus disease 2019 and are among the most promising technologies to address the current pandemic. Here, we show preclinical data for our clinical candidate CVnCoV, a lipid nanoparticle-encapsulated mRNA vaccine that encodes full-length, pre-fusion stabilised severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein. In contrast to previously published approaches, CVnCoV is exclusively composed of naturally occurring nucleotides. Immunisation with CVnCoV induced strong humoral responses with high titres of virus-neutralising antibodies and robust T-cell responses. CVnCoV vaccination protected hamsters from challenge with wild-type SARS-CoV-2, demonstrated by the absence of viral replication in the lungs. Hamsters vaccinated with a suboptimal dose of CVnCoV leading to breakthrough viral replication exhibited no evidence of vaccine-enhanced disease. Overall, data presented here provide evidence that CVnCoV represents a potent and safe vaccine candidate against SARS-CoV-2.
Article activity feed
-
-
SciScore for 10.1101/2020.10.23.351775: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Specific proteins were detected using rabbit anti-SARS Spike c-terminal (Abcam, Cat. ab252690) and mouse anti tubulin (Abcam, Cat. ab7291), followed by goat anti-rabbit IgG IRDye® 800CW (Li-Cor, Cat. 926-32211) and goat anti-mouse IgG IRDye® 680RD (Li-Cor, Cat. 926-68070), respectively. anti tubulinsuggested: NoneSpecific S protein expression was assessed via staining with Human anti SARS CoV S antibody (CR3022) anti SARS CoV Ssuggested: NoneCR3022suggested:…SciScore for 10.1101/2020.10.23.351775: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Specific proteins were detected using rabbit anti-SARS Spike c-terminal (Abcam, Cat. ab252690) and mouse anti tubulin (Abcam, Cat. ab7291), followed by goat anti-rabbit IgG IRDye® 800CW (Li-Cor, Cat. 926-32211) and goat anti-mouse IgG IRDye® 680RD (Li-Cor, Cat. 926-68070), respectively. anti tubulinsuggested: NoneSpecific S protein expression was assessed via staining with Human anti SARS CoV S antibody (CR3022) anti SARS CoV Ssuggested: NoneCR3022suggested: NoneMRO-1214LC) followed by goat anti-human IgG F(ab’)2 fragment PE antibody (Immuno Research, Cat. 109-116-097) in a BD FACS Canto II cell analyzer and the FlowJo 10 software. anti-human IgGsuggested: (Jackson ImmunoResearch Labs Cat# 109-116-097, RRID:AB_2337677)Antibody analysis: Blood samples were taken via retro-orbital bleeding and SARS-CoV-2 S-specific IgG1 and IgG2a antibodies (mice) or total IgG (hamster) antibodies were detected via ELISA. SARS-CoV-2 S-specific IgG1suggested: NoneS-specificsuggested: NoneIgG2asuggested: Nonetotal IgGsuggested: NoneFor detection, mouse sera were incubated with biotin rat anti-mouse IgG1 (BD Pharmingen, Cat. 550331) or biotin rat anti-mouse IgG2a (BD Pharmingen, Cat. 550332), hamster sera with biotin goat anti-hamster (Syrian) IgG antibody (BioLegend, Cat: 405601) followed by incubation with HRP-Streptavidin (BD, Cat: 554066). anti-mouse IgG1suggested: Noneanti-mouse IgG2asuggested: Noneanti-hamster ( Syrian ) IgGsuggested: NoneThe cells were then incubated with 200 ng/well of R-PE labelled rabbit anti-SARS-CoV-2 spike neutralizing monoclonal antibody (Sino Biological, Cat: 40592-R001) at 4°C for 2 h. anti-SARS-CoV-2suggested: NoneAntibody labelling with R-PE using the Zenon™ labelling kit for rabbit IgG (Invitrogen, Cat: Z25355) was performed according to the manufacturer’s instructions. rabbit IgGsuggested: NoneThe following antibodies were used for flow cytometry analysis: anti-Thy1.2 FITC (clone 53-2.1; Biolegend, Cat.14304) anti-Thy1.2 FITCsuggested: (Abcam Cat# ab24905, RRID:AB_448475)Experimental Models: Cell Lines Sentences Resources For detection of mRNA expression in cell culture, HeLa cells were seeded in 6-well plates at a density of 400.000 cells/well. 24h later, cells were transfected with 2μg of mRNA per well via Lipofection. HeLasuggested: NoneQuadruplicate, 10-fold serial dilutions were transferred to 96 well plates with Vero E6 cell culture monolayers and incubated for one hour at 37°C. Vero E6suggested: NoneExperimental Models: Organisms/Strains Sentences Resources Mice (BALB/c, 8-12 weeks of age) were obtained from Janvier Laboratories (Le Genest-Saint-Isle, France). BALB/csuggested: NoneSoftware and Algorithms Sentences Resources MRO-1214LC) followed by goat anti-human IgG F(ab’)2 fragment PE antibody (Immuno Research, Cat. 109-116-097) in a BD FACS Canto II cell analyzer and the FlowJo 10 software. FlowJosuggested: (FlowJo, RRID:SCR_008520)Antibody labelling with R-PE using the Zenon™ labelling kit for rabbit IgG (Invitrogen, Cat: Z25355) was performed according to the manufacturer’s instructions. Zenon™suggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
SciScore for 10.1101/2020.10.23.351775: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Female Balb/c mice (n=8/group) were vaccinated IM on day 0, day 7, day 14 or day 21 with 2 µg of CVnCoV. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Specific proteins were detected using rabbit anti-SARS Spike c-terminal (Abcam, Cat. ab252690) and mouse anti tubulin (Abcam, Cat. ab7291), followed by goat anti-rabbit IgG IRDye® 800CW (Li-Cor, Cat. 926-32211) and goat anti-mouse IgG IRDye® 680RD (Li-Cor, Cat. 926-68070), respectively. anti tubulin…SciScore for 10.1101/2020.10.23.351775: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Female Balb/c mice (n=8/group) were vaccinated IM on day 0, day 7, day 14 or day 21 with 2 µg of CVnCoV. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Specific proteins were detected using rabbit anti-SARS Spike c-terminal (Abcam, Cat. ab252690) and mouse anti tubulin (Abcam, Cat. ab7291), followed by goat anti-rabbit IgG IRDye® 800CW (Li-Cor, Cat. 926-32211) and goat anti-mouse IgG IRDye® 680RD (Li-Cor, Cat. 926-68070), respectively. anti tubulinsuggested: NoneSpecific S protein expression was assessed via staining with Human anti SARS CoV S antibody (CR3022) anti SARS CoV Ssuggested: NoneCR3022suggested: NoneMRO-1214LC) followed by goat anti-human IgG F(ab’)2 fragment PE antibody (Immuno Research, Cat. 109-116-097) in a BD FACS Canto II cell analyzer and the FlowJo 10 software. anti-human IgGsuggested: (Jackson ImmunoResearch Labs Cat# 109-116-097, RRID:AB_2337677)Antibody analysis Blood samples were taken via retro-orbital bleeding and SARS-CoV-2 S -specific IgG1 and IgG2a antibodies (mice) or total IgG (hamster) antibodies were detected via ELISA. IgG2asuggested: Nonetotal IgGsuggested: NoneFor detection, mouse sera were incubated with biotin rat anti-mouse IgG1 (BD Pharmingen, Cat. 550331) or biotin rat anti-mouse IgG2a (BD Pharmingen, Cat. 550332), hamster sera with biotin goat anti-hamster (Syrian) IgG antibody (BioLegend, Cat: 405601) followed by incubation with HRP-Streptavidin (BD, Cat: 554066). anti-mouse IgG1suggested: Noneanti-mouse IgG2asuggested: Noneanti-hamster ( Syrian ) IgGsuggested: NoneThe cells were then incubated with 200 ng/well of R-PE labelled rabbit anti-SARS-CoV-2 spike neutralizing monoclonal antibody (Sino Biological, Cat: 40592-R001) at 4°C for 2 h. anti-SARS-CoV-2suggested: (Abcam Cat# ab272854, RRID:AB_2847844)Antibody labelling with R-PE using the ZenonTM labelling kit for rabbit IgG (Invitrogen, Cat: Z25355) was performed according to the manufacturer’s instructions. rabbit IgGsuggested: NoneThe following antibodies were used for flow cytometry analysis: anti-Thy1.2 FITC (clone 53-2.1; Biolegend, Cat.14304) anti-Thy1.2 FITCsuggested: (Abcam Cat# ab41584, RRID:AB_778437)Each dot represents an individual animal, bars depict the median. SECD: S ectodomain, RBD: receptor binding domain of S, NTD: N-terminal domain of S, nAb: neutralising antibody A ✱✱ C total IgG endpoint titer [Log10] d28 d42 Log10suggested: NoneExperimental Models: Cell Lines Sentences Resources Quadruplicate, 10-fold serial dilutions were transferred to 96 well plates with Vero E6 cell culture monolayers and incubated for one hour at 37°C. Vero E6suggested: NoneHeLa cells were transfected with 2 µg of the mRNA component of CVnCoV. HeLasuggested: CLS Cat# 300194/p772_HeLa, RRID:CVCL_0030)Experimental Models: Organisms/Strains Sentences Resources For studies performed externally, Balb/c mice were provided and handled by Preclinics Gesellschaft für präklinische Forschung mbH, (Potsdam, Germany). Balb/csuggested: RRID:IMSR_ORNL:BALB/cRl)Bu ffe r ad + ot ei n pr C Vn C oV µg B D d35 d49 IgG1 endpoint titer 9 d28 8 6 5 4 3 2 1 0 9 8 7 6 5 4 3 2 1 0 1st vacc d0 d7 d14d21 d0 d0 2nd vacc none + d0 d7 d14d21 d0 d0 2 d28 1st vacc d0 d7 d14d21 d0 d0 2nd vacc none + d0 d7 d14d21 d0 d0 2suggested: NoneCVnCoV 2µg C d0 d7 d14d21 d0 d0 d28 protein + adj. C d0 d7 d14d21 d0 d0 d28 protein + adjsuggested: NoneIFN+/TNF+(% of CD4 T cells) IgG2a endpoint titer CD4 T-cells ✱✱ 0.8 0.6 0.4 0.2 0.0 d0 d7 d14 d21 d7 d7 + buffer CD8 T-cells 1st vacc 2nd vacc d28 d0 d7 d14 d21 d7 d7 none d35 d0 d7 d14 d21 d7 d7 d28 CVnCoV 2µg d7 d14 d21 d7 d7suggested: Nonevacc d28 d0 d7 d14 d21 d7 d7 none d35 d0 d7 d14 d21 d7 d7 d28suggested: Noned0 d7 d14 d21 d7 d7 d28 protein + adj. buffer IFN+ TNF+(% of CD8 T cells) VNT ✱✱✱ ✱✱ ✱✱ ✱ d0 d7 d14 d21 d7 d7 CVnCoV 2µg protein + adj. buffer Figure 2: CVnCoV elicits high levels of humoral and cellular immune responses. d0 d7 d14 d21 d7 d7 d28 protein + adjsuggested: NoneVNT ✱✱✱ ✱✱ ✱✱ ✱ d0 d7 d14 d21 d7 d7 CVnCoV 2µg protein + adjsuggested: None✱✱ d56 ✱✱ Throat swab titration [Log10 TCID50/ml] d5 d5 d5 d5 d6 d5 d5 d5 d5 d6 d5 d5 d5 d5 d6 untr. Log10 TCID50/ml ] d5 d5 d5 d5 d6 d5 d5 d5 d5 d6 d5 d5 d5 d5 d6suggested: NoneSoftware and Algorithms Sentences Resources Flow cytometry data were analyzed using FlowJo software (Tree Star, Inc, Ashland, USA.). FlowJosuggested: (FlowJo, RRID:SCR_008520)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).
Results from JetFighter: We did not find any issues relating to colormaps.
About SciScore
SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.
-
